Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Low iron and vitamin D levels are linked to hair loss in women.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Gastric exclusion surgery caused major weight loss and health improvements but led to some anemia and vitamin deficiencies.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Antiandrogen therapy helps treat genetic hair loss.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

PCOS is a major cause of infertility and requires personalized treatment.

Quick, selective detection of tadalafil and finasteride in human plasma developed.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

PCOS may increase the risk of high blood pressure and heart issues.